Edwards Lifesciences Corp., an Irvine-based medical device maker, said today that it received Food and Drug Administration clearance for its ClearSight device. ClearSight is an advanced noninvasive ...
Becton Dickinson plans to pay $4.2 billion for Edwards Lifesciences’ critical care business, which sells technology that monitors the heart conditions of critically ill patients. Edwards had told ...
Edwards Lifesciences Corp. said it’s fighting a $40.1 million punitive damage award stemming from a product liability lawsuit. The Irvine device maker has asked the Washington State Court of Appeals ...
Edwards Lifesciences (Irvine, CA) has announced that it has received FDA 510(k) approval for its ClearSight noninvasive monitor that, in conjunction with the company's EV1000 clinical platform, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results